| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1362 | 2020 |
| Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants M Yuan, D Huang, CCD Lee, NC Wu, AM Jackson, X Zhu, H Liu, L Peng, ... Science 373 (6556), 818-823, 2021 | 359 | 2021 |
| Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody CG Rappazzo, LV Tse, CI Kaku, D Wrapp, M Sakharkar, D Huang, ... Science 371 (6531), 823-829, 2021 | 307 | 2021 |
| Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection G Song, W He, S Callaghan, F Anzanello, D Huang, J Ricketts, JL Torres, ... Nature communications 12 (1), 2938, 2021 | 284 | 2021 |
| S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate W Qin, KE Qin, Y Zhang, W Jia, Y Chen, BO Cheng, L Peng, N Chen, ... Nature chemical biology 15 (10), 983-991, 2019 | 227 | 2019 |
| Artificial cysteine S‐glycosylation induced by per‐O‐acetylated unnatural monosaccharides during metabolic glycan labeling W Qin, K Qin, X Fan, L Peng, W Hong, Y Zhu, P Lv, Y Du, R Huang, M Han, ... Angewandte Chemie 130 (7), 1835-1838, 2018 | 168 | 2018 |
| A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection P Zhou, M Yuan, G Song, N Beutler, N Shaabani, D Huang, W He, X Zhu, ... Science translational medicine 14 (637), eabi9215, 2022 | 166* | 2022 |
| Broadly neutralizing antibodies target the coronavirus fusion peptide C Dacon, C Tucker, L Peng, CCD Lee, TH Lin, M Yuan, Y Cong, L Wang, ... Science 377 (6607), 728-735, 2022 | 140 | 2022 |
| Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern H Cho, KK Gonzales-Wartz, D Huang, M Yuan, M Peterson, J Liang, ... Science translational medicine 13 (616), eabj5413, 2021 | 97* | 2021 |
| Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease P Zhou, G Song, H Liu, M Yuan, W He, N Beutler, X Zhu, VT Longping, ... Immunity 56 (3), 669-686. e7, 2023 | 81* | 2023 |
| A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody NC Wu, M Yuan, S Bangaru, D Huang, X Zhu, CCD Lee, HL Turner, ... PLoS pathogens 16 (12), e1009089, 2020 | 66 | 2020 |
| A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection H Liu, M Yuan, D Huang, S Bangaru, F Zhao, CCD Lee, L Peng, ... Cell host & microbe 29 (5), 806-818. e6, 2021 | 56 | 2021 |
| A broad and potent neutralization epitope in SARS-related coronaviruses M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola, CY Zhu, X Yu, H Liu, ... Proceedings of the National Academy of Sciences 119 (29), e2205784119, 2022 | 50 | 2022 |
| One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening IM Francino-Urdaniz, PJ Steiner, MB Kirby, F Zhao, CM Haas, S Barman, ... Cell Reports 36 (9), 2021 | 42 | 2021 |
| Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses C Dacon, L Peng, TH Lin, C Tucker, CCD Lee, Y Cong, L Wang, L Purser, ... Cell host & microbe 31 (1), 97-111. e12, 2023 | 28 | 2023 |
| A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies F Ferrara, MF Erasmus, S D’Angelo, C Leal-Lopes, AA Teixeira, ... Nature communications 13 (1), 462, 2022 | 28 | 2022 |
| Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques W He, M Yuan, S Callaghan, R Musharrafieh, G Song, M Silva, N Beutler, ... Science translational medicine 14 (657), eabl9605, 2022 | 24 | 2022 |
| Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution F Zhao, M Yuan, C Keating, N Shaabani, O Limbo, C Joyce, J Woehl, ... Science Signaling 16 (798), eabk3516, 2023 | 13 | 2023 |
| Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways F Zhao, C Keating, G Ozorowski, N Shaabani, IM Francino-Urdaniz, ... Iscience 25 (9), 2022 | 7 | 2022 |
| A rapid assay for SARS-CoV-2 neutralizing antibodies that is insensitive to antiretroviral drugs D Huang, JT Tran, L Peng, L Yang, RT Suhandynata, MA Hoffman, ... The Journal of Immunology 207 (1), 344-351, 2021 | 5 | 2021 |
David NemazeeThe Scripps Research Institute在 scripps.edu 的电子邮件经过验证
